-
Keystone
—
1.8
An arthritis drug from the Swiss pharmaceutical company Roche is said to help coronavirus patients.
—-
Keystone
—
2.8
Actemra is the name of the arthritis drug that holds hope.
—-
AFP
—
3.8
China’s national health authority approved the use of the drug.
—-
AFP
—
7/8
However, a study that stratified in February is said to prove its effectiveness in fighting the virus.
—-
keystone-sda.ch
—
8.8
Roche has donated around $ 2 million to China since February.
—-
—-
Actemra is the means by which coronavirus patients are to save their lives. It is an arthritis remedy from the Swiss pharmaceutical company Roche. China’s national health agency is now approving the drug for severe coronavirus-induced lung damage with increased interleukin-6 levels.
–
According to Roche, Actemra could help curb inflammation, which the increased value indicates. So far, there is no clinical evidence of the effectiveness of the agent in coronavirus patients. In February, however, researchers in China launched a study to treat coronavirus patients with Actemra. According to Roche, this study is intended to demonstrate the safety and effectiveness of the drug in the fight against the virus.
–
Pharmaceutical giant donates medication to China
The pharmaceutical company has, according to its own information, donated to Actemra worth around two million dollars to China since February. Last year, the company generated $ 2.4 billion in revenue from the drug.
–
Worldwide, more than 94,000 people are now infected with the corona virus. So far, more than 3,200 have died from the effects of the virus. There are also over 50 infected people in Switzerland. (euc)
–
coronavirus—
The corona virus currently keeps the world in suspense. Many countries take measures such as closing schools or borders and restricting public events to prevent them from spreading. The virus has now also arrived in Switzerland. All current information and figures on the subject are available in the Coronavirus ticker.
——
Related
